> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 3 Observations in East Marietta FDA-483
- URL: https://www.fdaweb.com/3-observations-in-east-marietta-fda-483/
- Published: 2019-10-23T12:00:00.000Z
- Updated: 2026-09-15T01:58:18.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145317

FDA has released the FDA-483 issued following a 6/19-6/23 inspection at East Marietta Drug Company, Marietta, GA, a producer of non-sterile drug products. The three inspection observations on the [form](https://www.fda.gov/media/131670/download?ref=fdaweb.com) were: 

- production of highly potent drugs without providing adequate cleaning of work surfaces to prevent cross-contamination;
- failure of personnel to disinfect and change gloves frequently enough to prevent contamination; and
- non-microbial contamination observed in production area.